Antiproliferative effects of a flavonoid and saponins from Astragalus hamosus against human tumor cell lines

Pharmacognosy Magazine

Volumn 4, Issue 16, 2008, Pages 269-272

  Krasteva, I ^a   Momekov, G ^a   Zdraveva, P ^a   Konstantinov, S ^a   Nikolov, S ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Apoptosis; Astragalus hamosus; Fabaceae; Flavonoids; MTT assay; Saponins

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ASTRAGALUS HAMOSUS EXTRACT; ETOPOSIDE; FLAVONOID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; RHAMNOCITRIN 4' BETA DEXTRO GALACTOPYRANOSIDE; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTRAGALUS HAMOSUS; BIOASSAY; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IC 50; LEGUME; LEUKEMIA CELL LINE; MITOSIS INHIBITION; MULTIPLE MYELOMA; SOLVENT EXTRACTION;

EID: 69749088113     PISSN: 09731296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. R.N. Chopra, S.L. Nayar, I.C. Chopra, Glossary of Indian Medicinal Plants, (Council of Scientific and Industrial Research, New Delhi, 1986).
2. I. Krasteva, S. Platikanov, S. Nikolov and M. Kaloga. Flavonoids from Astragalus hamosus. Nat. Prod. Res. 21 (5), 392-395 (2007).
3. L. Verotta, M. Guerrini, N.A. El-Sebakhy, A.M. Assad, S.M. Toaima, M.M. Radwan, Y.D. Luo, J.M. Pezzuto. Cycloartane and oleanane saponins from egyptian astragalus spp. as modulators of lymphocyte proliferation. Planta Med. 68 (11): 986-994 (2002).
4. T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1-2): 55-63 (1983).
5. S.M. Konstantinov, H. Eibl and M.R. Berger. BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines. Br. J. Haematol. 107 (2): 365-380 (1999).
6. L.J. Rios and P.G. Waterman. A review of the pharmacology and toxicology of Astragalus. Phytother. Res. 11 (6): 411-418 (1997).
7. L. Pistelli. Secondary metabolites of genus Astragalus: Structure and biological activity. In: Atta-ur-Rahman, eds. Studies in Natural Products Chemistry (Bioactive Natural Products, Part H): Elsevier Science B.V.; 443-545 (2002).
8. I.N. Krasteva, R.A. Toshkova and S.D. Nikolov. Protective effect of Astragalus corniculatus saponins against myeloid Graffi tumour in hamsters. Phytother. Res. 18 (3): 255-257 (2004).
9. B.A. Chabner, P.C. Amrein, B.J. Druker, D. Michaelson, C.S. Mitsiades, P.E. Goss, D.P. Ryan, S. Ramachandra, P.G. Richardson, J.G. Supko and W.H. Wilson. Chemotherapy of neoplastic disease. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's: The pharmacological basis of therapeutics. McGraw Hill, New York; 1315-1403 (2006).
10. K.M. Giacomini, Y. Sugiyama. Membrane transporters and drug transport. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's: The pharmacological basis of therapeutics, McGraw Hill, New York; 41-71 (2006).
11. L.E. Horvath, S.M. Konstantinov, M.V. Ilarionova and D.K. Todorov. Effects of the plant alkaloid thaliblastine on non-cross-resistant and sensitive human leukemia cells in relation with reversal of acquired anthracycline resistance. Fitoterapia 75 (7-8): 712-717 (2004).